Results 101 - 150 of 383,200
Aluminum Extrusions From the People's Republic of China: Continuation of Antidumping and Countervailing Duty Orders
Document Number: 2017-08352
Type: Notice
Date: 2017-04-25
Agency: Department of Commerce, International Trade Administration
As a result of the determinations by the Department of Commerce (Department) and the International Trade Commission (ITC) that revocation of the antidumping duty (AD) and countervailing duty (CVD) orders on aluminum extrusions from the People's Republic of China would likely lead to a continuation or recurrence of dumping and countervailable subsidies and material injury to an industry in the United States, the Department is publishing a notice of continuation of the AD and CVD orders.
Government-Owned Inventions; Availability for Licensing
Document Number: 2017-08351
Type: Notice
Date: 2017-04-25
Agency: Department of Health and Human Services, National Institutes of Health
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Government-Owned Inventions; Availability for Licensing
Document Number: 2017-08350
Type: Notice
Date: 2017-04-25
Agency: Department of Health and Human Services, National Institutes of Health
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
National Institute on Aging; Notice of Closed Meeting
Document Number: 2017-08349
Type: Notice
Date: 2017-04-25
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Cancellation of Meeting
Document Number: 2017-08348
Type: Notice
Date: 2017-04-25
Agency: Department of Health and Human Services, National Institutes of Health
Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
Document Number: 2017-08347
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Cambridge Isotope Laboratories
Document Number: 2017-08346
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Janssen Ortho LLC
Document Number: 2017-08345
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2017-08344
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals
Document Number: 2017-08343
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection: Annual Parole Survey, Annual Probation Survey
Document Number: 2017-08342
Type: Notice
Date: 2017-04-25
Agency: Department of Justice
The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Prepaid Accounts Under the Electronic Fund Transfer Act (Regulation E) and the Truth in Lending Act (Regulation Z); Delay of Effective Date
Document Number: 2017-08341
Type: Rule
Date: 2017-04-25
Agency: Bureau of Consumer Financial Protection
The Bureau of Consumer Financial Protection (Bureau or CFPB) is issuing this final rule to delay the October 1, 2017 effective date of the rule governing Prepaid Accounts Under the Electronic Fund Transfer Act (Regulation E) and the Truth in Lending Act (Regulation Z) by six months, to April 1, 2018.
Adjustment of Nationwide Significant Risk Threshold
Document Number: 2017-08337
Type: Notice
Date: 2017-04-25
Agency: Federal Railroad Administration, Department of Transportation
Under title 49 Code of Federal Regulations, Use of Locomotive Horns at Public Highway-Rail Grade Crossings, FRA is updating the Nationwide Significant Risk Threshold (NSRT). This action is needed to ensure the public has the proper permissible risk threshold to evaluate risk resulting from prohibiting routine locomotive horn sounding at highway-rail grade crossings located in quiet zones. This is the seventh update to the NSRT and it is increasing from 14,347 to 14,723.
Agency Information Collection Activity: Board of Veterans' Appeals Voice of the Veteran Appellant Satisfaction Survey
Document Number: 2017-08336
Type: Notice
Date: 2017-04-25
Agency: Department of Veterans Affairs
The Board of Veterans' Appeals (Board), Department of Veterans Affairs (VA), is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act (PRA) of 1995, Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of a currently approved collection, and allow 60 days for public comment in response to the notice.
Combined Notice of Filings
Document Number: 2017-08335
Type: Notice
Date: 2017-04-25
Agency: Department of Energy, Federal Energy Regulatory Commission
Combined Notice of Filings #1
Document Number: 2017-08334
Type: Notice
Date: 2017-04-25
Agency: Department of Energy, Federal Energy Regulatory Commission
Commission Information Collection Activities; Comment Request for Generic Clearance for the Collection of Qualitative Feedback on Commission Service Delivery
Document Number: 2017-08333
Type: Notice
Date: 2017-04-25
Agency: Department of Energy, Federal Energy Regulatory Commission
As part of a Federal Government-wide effort to streamline the process to seek feedback from the public on service delivery, the Federal Energy Regulatory Commission (the Commission or FERC) is coordinating the development of the proposed Generic Information Collection Request (ICR), FERC-153, Generic Clearance for the Collection of Qualitative Feedback on Commission Service Delivery, for approval under the Paperwork Reduction Act (PRA).\1\ This notice announces that FERC intends to submit this collection to Office of Management and Budget (OMB) for approval and solicits comments on specific aspects for the proposed information collection. Previously, the Commission published a 60-day notice in the Federal Register (81 FR 70402, 10/12/2016) and received no comments.
Announcement of the Housing Counseling Federal Advisory Committee Notice of Public Meeting
Document Number: 2017-08331
Type: Notice
Date: 2017-04-25
Agency: Department of Housing and Urban Development
This gives notice of a Housing Counseling Federal Advisory Committee (HCFAC) meeting and sets forth the proposed agenda. The Committee meeting will be held on Monday, May 15, 2017. The meeting is open to the public and is accessible to individuals with disabilities.
Information Collection: Enforcement Discretion for Operating Reactors and Gaseous Diffusion Plants
Document Number: 2017-08330
Type: Notice
Date: 2017-04-25
Agency: Nuclear Regulatory Commission, Agencies and Commissions
The U.S. Nuclear Regulatory Commission (NRC) invites public comment on the renewal of Office of Management and Budget (OMB) approval for an existing collection of information. The information collection is entitled, ``Notice of Enforcement Discretion (NOED) for Operating Power Reactors and Gaseous Diffusion Plants (NRC Enforcement Policy).''
Notice of Mailing/Street Address Change for the BLM-Challis Field Office, Idaho
Document Number: 2017-08329
Type: Notice
Date: 2017-04-25
Agency: Department of the Interior, Bureau of Land Management
The mailing/street address for the Bureau of Land Management (BLM) Challis Field Office will change from 1151 Blue Mountain Road, Challis, Idaho 83226 to street address 721 East Main Avenue, Suite 8, Challis, Idaho 83226 and mailing address P.O. Box 817, Challis, Idaho 83226.
Certain Hardwood Plywood Products From the People's Republic of China: Preliminary Affirmative Countervailing Duty Determination, Preliminary Affirmative Critical Circumstances Determination, in Part, and Alignment of Final Determination With Final Antidumping Duty Determination
Document Number: 2017-08328
Type: Notice
Date: 2017-04-25
Agency: Department of Commerce, International Trade Administration
The Department of Commerce (Department) preliminarily determines that countervailable subsidies are being provided to producers and exporters of certain hardwood plywood products (hardwood plywood) from the People's Republic of China (PRC). The period of investigation is January 1, 2015, through December 31, 2015.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Institutional Review Boards
Document Number: 2017-08327
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (PRA).
Extending Expiration Dates of Doxycycline Tablets and Capsules in Strategic Stockpiles; Draft Guidance for Government Public Health and Emergency Response Stakeholders; Availability
Document Number: 2017-08326
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for government public health and emergency response stakeholders entitled ``Extending Expiration Dates of Doxycycline Tablets and Capsules in Strategic Stockpiles.'' This document, once finalized, will provide guidance to government stakeholders on testing to extend the shelf life (i.e., expiration date) under the Federal Food, Drug, and Cosmetic Act (the FD&C Act) of stockpiled doxycycline tablets and capsules for public health emergency preparedness and response purposes for an anthrax emergency. This draft guidance has been prepared in response to requests from States asking FDA what would be necessary to provide confidence that stockpiled doxycycline tablets and capsules have retained their original quality beyond the manufacturer's labeled expiration date so the replacement of stockpiled product could be deferred. This guidance and any resulting expiration date extensions authorized by FDA do not apply to doxycycline available commercially or otherwise held for any other non- emergency purpose.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions
Document Number: 2017-08325
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Information Collection Activity; Comment Request
Document Number: 2017-08324
Type: Notice
Date: 2017-04-25
Agency: Department of Agriculture, Rural Utilities Service
In accordance with the Paperwork Reduction Act of 199, the Rural Utilities Service (RUS) invites comments on this information collection for which RUS intends to request approval from the Office of Management and Budget (OMB).
Notice of Request for Revision of a Currently Approved Information Collection
Document Number: 2017-08323
Type: Notice
Date: 2017-04-25
Agency: Department of Agriculture, Rural Business-Cooperative Service
In accordance with the Paperwork Reduction Act of 1995, the Rural Business-Cooperative Service gives notice that it is requesting from the Office of Management and Budget (OMB) approval of a revision to a currently approved information collection for the Advanced Biofuel Payment Program.
Agency Information Collection Activities; Comment Request; International Early Learning Study (IELS) 2018 Field Test Data Collection and Main Study Recruitment
Document Number: 2017-08322
Type: Notice
Date: 2017-04-25
Agency: Department of Education
In accordance with the Paperwork Reduction Act of 1995, ED is proposing a revision of an existing information collection.
Limited-Access Highway Classification Codes
Document Number: 2017-08320
Type: Notice
Date: 2017-04-25
Agency: Department of Commerce, Bureau of the Census
The Bureau of the Census (U.S. Census Bureau) publishes this notice to request public comment on a proposal to change the classification of limited-access highways in the Census Bureau's Master Address File/Topologically Integrated Referencing and Encoding (MAF/ TIGER) System. The change will assign all limited-access highways a MAF/TIGER Feature Classification Code (MTFCC) of S1100 (Primary Roads). Currently, the classification code for limited-access highways is either S1100 (Primary Roads) or S1200 (Secondary Roads).
Drawbridge Operation Regulation; Arthur Kill, Staten Island, NY & Elizabeth, NJ
Document Number: 2017-08316
Type: Rule
Date: 2017-04-25
Agency: Coast Guard, Department of Homeland Security
The Coast Guard has issued a temporary deviation from the operating schedule that governs the Arthur Kill (AK) Railroad Bridge across the Arthur Kill, mile 11.6, at Staten Island, New York and Elizabeth, New Jersey. This temporary deviation is necessary to allow the bridge to remain in the closed-to-navigation position to facilitate structural inspections.
Submission for OMB Review; Comment Request
Document Number: 2017-08315
Type: Notice
Date: 2017-04-25
Agency: Department of Agriculture
Cybersecurity of Medical Devices: A Regulatory Science Gap Analysis; Public Workshop; Request for Comments
Document Number: 2017-08314
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, the Agency, or we), in association with National Science Foundation (NSF) and Department of Homeland Security, Science and Technology (DHS S&T) is announcing the following public workshop entitled ``Cybersecurity of Medical Devices: A Regulatory Science Gap Analysis.'' The objective of the workshop is to facilitate a discussion on the current state of regulatory science in the field of cybersecurity of medical devices, with a focus on patient safety. The purpose of this public workshop is to catalyze collaboration among Health Care and Public Health (HPH) stakeholders to identify regulatory science challenges, discuss innovative strategies to address those challenges, and encourage proactive development of analytical tools, processes, and best practices by the stakeholder community to strengthen medical device cybersecurity.
Receipt of Application for Incidental Take Permit; Low-Effect Habitat Conservation Plan for the Phillips 66 Cal Coast Pipeline Replacement Project, Santa Barbara County, California
Document Number: 2017-08313
Type: Notice
Date: 2017-04-25
Agency: Fish and Wildlife Service, Department of the Interior
We, the U.S. Fish and Wildlife Service, have received an application from Phillips 66 Pipeline LLC, for an incidental take permit under the Endangered Species Act of 1973, as amended. The permit would authorize take of the federally endangered California tiger salamander (Santa Barbara distinct population segment) and the threatened California red-legged frog, incidental to otherwise lawful activities associated with the Cal Coast Pipeline Replacement Project Habitat Conservation Plan. We invite public comment.
Agency Information Collection Activities: Revision to a Currently Approved Collection; Comments Requested: Diversity in Law Enforcement Recruitment Survey
Document Number: 2017-08312
Type: Notice
Date: 2017-04-25
Agency: Department of Justice
The Department of Justice (DOJ) Office of Community Oriented Policing Services (COPS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The information collection is a new instrument.
Sanctions Actions Pursuant to the Foreign Narcotics Kingpin Designation Act
Document Number: 2017-08310
Type: Notice
Date: 2017-04-25
Agency: Department of the Treasury, Office of Foreign Assets Control
The U.S. Department of the Treasury's Office of Foreign Assets Control (OFAC) is publishing the names of two entities whose property and interests in property are blocked pursuant to the Foreign Narcotics Kingpin Designation Act (Kingpin Act).
Issuance of Priority Review Voucher; Rare Pediatric Disease Product
Document Number: 2017-08309
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Food and Drug Administration Safety and Innovation Act (FDASIA), authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher. FDA has determined that EMFLAZA (deflazacort) oral tablets, and oral suspension manufactured by Marathon Pharmaceuticals, LLC, meets the criteria for a priority review voucher.
Food and Drug Administration Small Business and Industry Assistance Regulatory Education for Industry Spring Conference; Public Conference
Document Number: 2017-08308
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), together with the Center for Devices and Radiological Health (CDRH), is sponsoring a 2-day public conference entitled ``FDA Small Business and Industry Assistance Regulatory Education for Industry (REdI) Spring Conference.'' The goal of this public conference is to provide direct, relevant, and helpful information on the key aspects of drug and medical device regulations in order to increase regulatory certainty and predictability for pharmaceutical and/or medical device industry. Our primary audience is that of small manufacturers of drug and/or medical devices who want to learn about how FDA approaches the regulation of drugs and medical devices and for whom increased certainty and predictability will help to decrease the regulatory burdens that can be associated with a lack of understanding of, or familiarity with, FDA's drug and medical device regulations. However, anyone involved in the pharmaceutical and/or medical device industry may attend.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act
Document Number: 2017-08307
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry: Use of Serological Tests To Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components for Transfusion
Document Number: 2017-08306
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA).
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Establishment Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution and Blood Establishment Registration and Product Listing
Document Number: 2017-08305
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that two collections of information: ``Establishment Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution'' and ``Blood Establishment Registration and Product Listing'' have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Regulations for Nonclinical Studies
Document Number: 2017-08304
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's good laboratory practice (GLP) regulations for nonclinical laboratory studies.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Certification of Identity for Freedom of Information Act and Privacy Act Requests
Document Number: 2017-08303
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Sentinel Training at the Food and Drug Administration; Public Workshop
Document Number: 2017-08302
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled ``Sentinel Training at FDA.'' The purpose of the public workshop is to provide training to understand the kinds of questions that can be asked using health care claims data generally and within the FDA Sentinel System specifically, allowing an understanding of the capabilities of the Sentinel System.
Pediatric Studies of Ampicillin Conducted in Accordance With the Public Health Service Act
Document Number: 2017-08301
Type: Notice
Date: 2017-04-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is making available to the public a report, submitted by Duke Clinical Research Institute on December 15, 2015, of the pediatric studies of ampicillin that were conducted in accordance with the Public Health Service Act (PHS Act) and submitted to the Director of the National Institutes of Health (NIH) and the Commissioner of Food and Drugs. This notice is to announce the 30-day open public comment period on the report.